Shopping Cart
- Remove All
- Your shopping cart is currently empty
EC330, a novel steroidal LIF inhibitor showed cytotoxicity in various cancer cell lines and NCI-60 cell line panel at low nano-molar range.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
1 mg | $85 | In Stock | |
5 mg | $247 | In Stock | |
10 mg | $352 | In Stock | |
25 mg | $595 | In Stock | |
50 mg | $848 | In Stock | |
100 mg | $1,170 | In Stock | |
1 mL x 10 mM (in DMSO) | $282 | In Stock |
Description | EC330, a novel steroidal LIF inhibitor showed cytotoxicity in various cancer cell lines and NCI-60 cell line panel at low nano-molar range. |
In vitro | EC330 blocked formation of colonies in soft agar and inhibited angiogenesis (tube formation) in human umbilical vein endothelial cells. EC330 binds to LIF/LIFR complex by insilico docking studies and reduced the STAT3 phosphorylation in a dose dependent manner through blocking LIF-JAK-STAT signaling. EC330 showed marked specificity in MCF-7 cells overexpressing LIF verses MCF-7 cells. The compound further showed cytoskeletal disruption and targeting cancer associated fibroblasts (CAFs). |
In vivo | EC330 treatment (0.5 and 2.5mg/kg) dose dependently reduced tumor burden in ovarian (IGROV-1) and triple negative breast cancer (MDA-MB-231) cell xenografted mouse models. |
Molecular Weight | 462.57 |
Formula | C30H32F2O2 |
Cas No. | 2016795-77-8 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. | |||||||||||||||||||||||||
Solubility Information | DMSO: 20 mg/mL (43.24 mM) | |||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||
DMSO
|
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.